Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

PlushCare vs Enhance MD

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.0

PlushCare

Best for readers who want a primary-care relationship with GLP-1 prescribing as one option, AND who read the class-action disclosure and verify the cancellation flow before subscribing
★★★3.5

Starting at $149/mo

Virtual Primary CareBrand WegovyBrand ZepboundBrand Ozempic
Visit PlushCare
8.6

Enhance MD

Best for lab-monitored compounded GLP-1 with mandatory video visit
★★★★4.3

Starting at $49/mo

CompoundedSemaglutideTirzepatideQuest Diagnostics Labs Included
Visit Enhance MD

Side-by-Side Comparison

FeaturePlushCareEnhance MD
Overall Score7.0/108.6/10
Starting Price$149/mo$49/mo
Editorial Rating3.5 ★ /54.3 ★ /5
Features7 features6 features
States Available5039
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

PlushCare

Pros

  • All 50 states per the homepage
  • Appointments with US board-certified physicians (not nurse practitioners only)
  • Operates as virtual primary care, so the same provider can write GLP-1 prescriptions alongside other primary-care needs
  • Owned by Transcarent (post-Accolade-acquisition), a venture-backed health platform with named corporate parent

Cons

  • ACTIVE LITIGATION: California class action alleging deceptive subscription enrollment and unauthorized post-cancellation charges on the $19.99/month membership. Material disclosure for any reader signing up.
  • GLP-1 prescribing is clinician-discretionary at the visit level — not a guaranteed offering at intake
  • BBB rating reflects an ongoing pattern of complaints around the membership cancellation flow

Enhance MD

Pros

  • Baseline and ongoing metabolic lab panels (CMP, lipids, TSH, HbA1c) at Quest Diagnostics every 6 months — a rigor most compounded GLP-1 providers skip entirely
  • Mandatory one-on-one video visit with a US-licensed MD or NP before the first prescription — not a pure-async questionnaire model
  • Three pricing tiers including a combined semaglutide + tirzepatide Elite plan ($322/mo ongoing) — useful for patients plateaued on a single GLP-1
  • LegitScript-certified 503A pharmacy network: Tru Meds Rx, Strive Pharmacy, Pharmacy Hub
  • Aggressive first-month intro pricing: $49 on Core, $99 on Advanced, $189 on Elite
  • Unlimited clinician messaging and dose-adjustment support included

Cons

  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro option
  • Not available in 10 states: Alabama, Arkansas, Georgia, Hawaii, Louisiana, Mississippi, Missouri, South Carolina, Tennessee, West Virginia
  • Mandatory lab work adds 5–10 days to onboarding vs. async-only competitors
  • No insurance accepted — cash pay, HSA/FSA eligible
  • First-month intro pricing resets to full tier rate after 30 days — the $49/$99/$189 numbers are not the ongoing cost

Our Verdict

Winner: Enhance MDScore: 8.6/10

Enhance MD edges out PlushCare with a higher overall score of 8.6/10 and is particularly strong for lab-monitored compounded GLP-1 with mandatory video visit. PlushCare remains a solid alternative, especially if you're looking for readers who want a primary-care relationship with GLP-1 prescribing as one option, AND who read the class-action disclosure and verify the cancellation flow before subscribing.

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring PlushCare and Enhance MD head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.